国药集团药业股份有限公司公布2025年度分红实施方案，现金红利派发引关注
要点摘要
- 2025年度每股现金红利0.8元（含税），分红总额超6亿元。
- 2026年6月17日为股权登记日，6月18日为除权（息）日及红利发放日。
- 个人股东分红所得税将根据持股期限差异化征收，QFII及沪港通投资者按10%代扣税。
- 方案已获2026年4月22日年度股东大会通过。
分红详细方案
国药集团药业股份有限公司（证券代码：600511）于2026年6月12日发布公告，明确2025年年度利润分配方案已于2026年4月22日年度股东大会审议通过。本次分红以公司当前总股本754,502,998股为基数，每股现金红利为0.8元（含税），合计派发603,602,398.40元（含税），为公司股东带来稳定的现金回报。
关键日期提醒
| 股份类别 | 股权登记日 | 除权（息）日 | 现金红利发放日 |
|---|---|---|---|
| A股 | 2026/6/17 | 2026/6/18 | 2026/6/18 |
实施细则及注意事项
- 分派对象： 所有在2026年6月17日（股权登记日）收市后，在中国证券登记结算有限责任公司上海分公司登记在册的股东均可参与分红。
- 红利发放方式： 无限售条件流通股东的红利将通过中国结算上海分公司资金清算系统发放。已办理指定交易投资者可在红利发放日于指定证券营业部领取红利，未办理指定交易的暂由中国结算上海分公司保管，待办理后发放。公司控股股东国药控股股份有限公司的现金红利由公司直接发放。
- 税收政策：
- 个人股东和证券投资基金：持股超1年暂免征收个人所得税，实际每股获0.80元。持股1年及以内暂不扣税，转让时再计税，税负视持股期限（1个月内20%，1个月以上至1年10%，超1年免税）。
- QFII（合格境外机构投资者）：公司按10%税率代扣代缴，税后每股红利0.72元。若享有税收协定待遇可自行申请。
- 沪港通投资者：公司按10%税率代扣，税后每股红利0.72元，可申请协定待遇。
- 其他机构投资者：红利所得税自行缴纳，税前每股0.80元。
- 差异化分红送转： 本次不实施差异化分红送转。
可能影响股价的因素
- 稳定高额分红：此次每股0.8元的高额分红，显示公司良好的盈利能力和对股东的回报意愿，有望提升投资者信心，对公司股价形成积极影响。
- 分红税务优化：对持股期限1年以上的个人投资者免税，提升长期持有的吸引力，可能促使部分投资者延长持股周期，减少短期抛售压力。
- 现金流充裕：派现总额超6亿元，反映公司现金流状况良好，增强市场对公司财务稳健的预期。
- 外资参与便利：QFII及沪港通投资者税务安排明确，有助于吸引更多境外资金配置公司股票。
- 重要时间窗口提醒：投资者需关注6月17日股权登记日，确保在分红权益内。
投资者须知
投资者如对本次分红有疑问，可联系公司董事会办公室（电话：010-67271828）咨询。红利发放及税务等细节需根据自身持股情况及相关法规提前规划，以便获得最大化收益。
免责声明
本报道内容仅供投资者参考，不构成任何投资建议或邀约。投资者应根据自身情况、市场环境及专业意见独立判断相关投资风险。公司公告信息如有变动，请以官方最新公告为准。
Sinopharm Group Pharmaceutical Co., Ltd. Announces 2025 Dividend Distribution Plan: Substantial Cash Dividend to Shareholders
Key Highlights
- RMB 0.8 (pre-tax) cash dividend per share for 2025; total payout exceeds CNY 600 million.
- Shareholder record date: June 17, 2026. Ex-dividend and distribution date: June 18, 2026.
- Personal income tax on dividends is differentiated by holding period; QFII and Stock Connect investors subject to 10% withholding tax.
- Plan approved by the annual shareholders’ meeting on April 22, 2026.
Dividend Details
Sinopharm Group Pharmaceutical (Stock code: 600511) announced on June 12, 2026, that its 2025 profit distribution plan was approved at the April 22, 2026, shareholders’ meeting. Based on the current total share capital of 754,502,998 shares, a cash dividend of RMB 0.8 per share (pre-tax) will be distributed, totaling RMB 603,602,398.40 (pre-tax), delivering a stable return to shareholders.
Important Dates
| Share Class | Record Date | Ex-dividend Date | Dividend Payment Date |
|---|---|---|---|
| A Shares | 2026/6/17 | 2026/6/18 | 2026/6/18 |
Implementation and Important Details
- Eligible shareholders: All shareholders registered with China Securities Depository and Clearing Corporation Shanghai Branch as of the close of trading on June 17, 2026, are eligible for the dividend.
- Distribution method: For unrestricted tradable shares, dividends will be paid via the clearing system to shareholders with designated trading accounts. Those without designated trading will have their dividends temporarily kept, to be distributed after designation. Dividends for the controlling shareholder, Sinopharm Holdings Co., Ltd., will be paid directly.
- Tax policy:
- Individual shareholders and securities investment funds: Holding over one year, dividend income is temporarily exempt from personal income tax (receive RMB 0.80 per share). Holding within one year, tax is deferred and determined upon share transfer (20% for ≤1 month; 10% for >1 month to ≤1 year; exempt for >1 year).
- QFII: 10% withholding tax, after-tax dividend RMB 0.72/share. Application for tax treaty benefits possible.
- Stock Connect (Hong Kong): 10% tax withheld, after-tax RMB 0.72/share. Tax treaty application permitted.
- Other institutional investors: Responsible for their own tax; pre-tax dividend RMB 0.80/share.
- No differentiated bonus issue or stock transfer in this round.
Potential Price-sensitive Factors
- Strong Dividend Yield: The high cash dividend demonstrates robust profitability and intent to reward shareholders, likely enhancing investor confidence and supporting share price.
- Tax Optimization for Long-Term Holders: Tax exemption for holdings over one year encourages long-term investment, potentially reducing short-term sell pressure.
- Healthy Cash Flow: Payout over RMB 600 million reflects solid financial strength, improving market expectations of the company’s stability.
- Clear Tax Arrangements for Foreign Investors: QFII and Stock Connect investors benefit from transparent tax rules, possibly boosting international participation.
- Key Date Reminder: Investors should ensure eligibility by holding shares on June 17, 2026.
Investor Notice
For questions regarding this dividend, contact the company’s board office at 010-67271828. Details on dividend distribution and tax policies depend on personal holdings and may require advance planning to maximize returns.
Disclaimer
This news report is for informational purposes only and does not constitute investment advice or solicitation. Investors should make independent investment decisions based on their circumstances, market conditions, and professional advice. Please refer to official company announcements for the most up-to-date information.
